{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:33:27Z","timestamp":1794458007497,"version":"4.9.1"},"reference-count":201,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"JST","doi-asserted-by":"publisher","award":["JPMJSP2109"],"award-info":[{"award-number":["JPMJSP2109"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.neubiorev.2025.106209","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T10:58:21Z","timestamp":1747047501000},"page":"106209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Demyelination in psychiatric and neurological disorders: Mechanisms, clinical impact, and novel therapeutic strategies"],"prefix":"10.1016","volume":"174","author":[{"given":"Rumi","family":"Murayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9621-5832","authenticated-orcid":false,"given":"Yi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neubiorev.2025.106209_bib1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1474-4422(22)00471-9","article-title":"Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy","volume":"22","author":"Aloisi","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2025.106209_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis -an updated review","volume":"71","author":"Alqahtani","year":"2023","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106209_bib3","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.3390\/ijms24043754","article-title":"Alzheimer's disease: an updated overview of its genetics","volume":"24","author":"Andrade-Guerrero","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2025.106209_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104511","article-title":"The complex genetic architecture of Alzheimer's disease: novel insights and future directions","volume":"90","author":"Andrews","year":"2023","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106209_bib5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamapsychiatry.2017.2573","article-title":"Association of white matter structure with autism spectrum disorder and attention-deficit\/hyperactivity disorder","volume":"74","author":"Aoki","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106209_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104922","article-title":"Association between diffusion tensor imaging, inflammation and immunological alterations in unipolar and bipolar depression: a review","volume":"143","author":"Aronica","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"S1","key":"10.1016\/j.neubiorev.2025.106209_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/cen3.12576","article-title":"Mechanism of demyelination and remyelination in multiple sclerosis","volume":"11","author":"Bando","year":"2020","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.neubiorev.2025.106209_bib8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.nicl.2013.03.016","article-title":"White matter microstructural abnormalities in bipolar disorder: a whole brain diffusion tensor imaging study","volume":"2","author":"Barysheva","year":"2013","journal-title":"Neuroimage Clin."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106209_bib9","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2174\/1570159X22666240124114126","article-title":"Disease modifying strategies in multiple sclerosis: new rays of hope to combat disability?","volume":"22","author":"Bellanca","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neubiorev.2025.106209_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fpsyt.2016.00021","article-title":"DTI and myelin plasticity in bipolar disorder: integrating neuroimaging and neuropathological findings","volume":"7","author":"Bellani","year":"2016","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106209_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/bdi.70010","article-title":"White matter, cognition, and electrophysiological variables in bipolar disorder: using multimodal integration of biomarker variables associated with bipolar disorder to elucidate deficits","author":"Berardi","year":"2025","journal-title":"Bipolar Disord."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106209_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.devcel.2015.01.016","article-title":"Dynamics and mechanisms of CNS myelination","volume":"32","author":"Bercury","year":"2015","journal-title":"Dev. Cell"},{"key":"10.1016\/j.neubiorev.2025.106209_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuroimage.2017.02.056","article-title":"Structural properties of the human corpus callosum: multimodal assessment and sex differences","volume":"152","author":"Bj\u00f6rnholm","year":"2017","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106209_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrneurol.2011.21","article-title":"White matter lesions in Parkinson disease","volume":"7","author":"Bohnen","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106209_bib16","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1038\/s41380-021-01093-2","article-title":"Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability","volume":"26","author":"Bonaventura","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"6569","key":"10.1016\/j.neubiorev.2025.106209_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba6905","article-title":"Myelin: a gatekeeper of activity-dependent circuit plasticity?","volume":"374","author":"Bonetto","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2025.106209_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1165324","article-title":"Spatial patterns of white matter hyperintensities: a systematic review","volume":"15","author":"Botz","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"25","key":"10.1016\/j.neubiorev.2025.106209_bib19","first-page":"00127","article-title":"Association between peripheral inflammation and body mass index on white matter integrity and free water in bipolar II depression","volume":"S0889-1591","author":"Cao","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106209_bib20","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/schbul\/sbs053","article-title":"Alterations in white matter evident before the onset of psychosis","volume":"38","author":"Carletti","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106209_bib21","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41386-022-01272-x","article-title":"White-matter free-water diffusion MRI in schizophrenia: a systematic review and meta-analysis","volume":"47","author":"Carreira Figueiredo","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106209_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105677","article-title":"Is white matter hyperintensity burden associated with cognitive and motor impairment in patients with Parkinson's disease? a systematic review and meta-analysis","volume":"161","author":"Carvalho de Abreu","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"20","key":"10.1016\/j.neubiorev.2025.106209_bib23","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217635120","article-title":"MWF of the corpus callosum is a robust measure of remyelination: results from the ReBUILD trial","volume":"120","author":"Caverzasi","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2025.106209_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainresbull.2022.02.004","article-title":"Brain-gut-microbiota axis in depression: a historical overview and future directions","volume":"182","author":"Chang","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2025.106209_bib25","article-title":"Disorganization of white matter architecture in major depressive disorder: a meta-analysis of diffusion tensor imaging with tract-based spatial statistics","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106209_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3487","article-title":"5Z-7-Oxozaenol attenuates cuprizone-induced demyelination in mice through microglia polarization regulation","volume":"14","author":"Chen","year":"2024","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12929-022-00839-6","article-title":"Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis","volume":"29","author":"Chen","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neubiorev.2025.106209_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101911","article-title":"Abnormal white matter changes in Alzheimer's disease based on diffusion tensor imaging: A systematic review","volume":"87","author":"Chen","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106209_bib29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-022-00697-8","article-title":"The role of the gut microbiota in multiple sclerosis","volume":"18","author":"Correale","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2025.106209_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1135540","article-title":"Central nervous system demyelinating diseases: glial cells at the hub of pathology","volume":"14","author":"Coutinho Costa","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106209_bib31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/acn3.52017","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: a practical review","volume":"11","author":"Coyle","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106209_bib32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s40273-021-01032-7","article-title":"Economic burden of multiple sclerosis in low- and middle-income countries: a systematic review","volume":"39","author":"Dahham","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.neubiorev.2025.106209_bib33","doi-asserted-by":"crossref","first-page":"c3666","DOI":"10.1136\/bmj.c3666","article-title":"The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis","volume":"341","author":"Debette","year":"2010","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106209_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1192\/bjp.bp.112.118307","article-title":"Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies","volume":"202","author":"Diniz","year":"2013","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106209_bib35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/npr2.12471","article-title":"Correlation between myelin basic protein levels in cerebrospinal fluid and motor speed in patients with schizophrenia","volume":"44","author":"Enokida","year":"2024","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.neubiorev.2025.106209_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.662807","article-title":"Exploring the gut-brain axis for the control of CNS inflammatory demyelination: Immunomodulation by Bacteroides fragilis' polysaccharide A","volume":"12","author":"Erturk-Hasdemir","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106209_bib37","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/schbul\/sbaa052","article-title":"Evidence for altered metabolism of sphingosine-1-phosphate in the corpus callosum of patients with schizophrenia","volume":"46","author":"Esaki","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2025.106209_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577700","article-title":"The second brain: The connection between gut microbiota composition and multiple sclerosis","volume":"360","author":"Farshbafnadi","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"13","key":"10.1016\/j.neubiorev.2025.106209_bib39","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41386-019-0485-6","article-title":"Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals","volume":"44","author":"Favre","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106209_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tins.2023.11.003","article-title":"White matter injury across neurodegenerative disease","volume":"47","author":"Festa","year":"2024","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106209_bib42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1176\/appi.neuropsych.21010018","article-title":"White matter disease and psychiatric dysfunction: clinical and neurobiological insights","volume":"33","author":"Filley","year":"2021","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106209_bib43","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S2215-0366(24)00291-8","article-title":"Associations between white matter microstructure and cognitive decline in major depressive disorder versus controls in Germany: a prospective case-control cohort study","volume":"11","author":"Flinkenfl\u00fcgel","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106209_bib44","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.mp.4001337","article-title":"Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins","volume":"8","author":"Flynn","year":"2003","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106209_bib45","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS myelin\u2013from mechanisms to experimental medicines","volume":"18","author":"Franklin","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"21","key":"10.1016\/j.neubiorev.2025.106209_bib46","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.neuron.2022.09.023","article-title":"CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities","volume":"110","author":"Franklin","year":"2022","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106209_bib47","doi-asserted-by":"crossref","first-page":"a041371","DOI":"10.1101\/cshperspect.a041371","article-title":"Remyelination in the central nervous system","volume":"16","author":"Franklin","year":"2024","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106209_bib48","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/alz.12410","article-title":"White matter hyperintensity topography in Alzheimer's disease and links to cognition","volume":"18","author":"Garnier-Crussard","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106209_bib49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"5","author":"GBD 2016 Alcohol and Drug Use Collaborators","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib50","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","journal-title":"Lancet Public Health"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106209_bib52","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1038\/s41380-024-02547-z","article-title":"The genetic landscape of substance use disorders","volume":"29","author":"Gerring","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"13","key":"10.1016\/j.neubiorev.2025.106209_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143774","article-title":"Targeting the gut to treat multiple sclerosis","volume":"131","author":"Ghezzi","year":"2021","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.neubiorev.2025.106209_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nicl.2013.07.007","article-title":"White matter microstructure correlates with autism trait severity in a combined clinical-control sample of high-functioning adults","volume":"3","author":"Gibbard","year":"2013","journal-title":"Neuroimage Clin."},{"issue":"18","key":"10.1016\/j.neubiorev.2025.106209_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/hbm.70104","article-title":"segcsvdWMH: A Convolutional Neural Network-Based Tool for Quantifying White Matter Hyperintensities in Heterogeneous Patient Cohorts","volume":"45","author":"Gibson","year":"2024","journal-title":"Hum. Brain Mapp."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106209_bib56","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000002898","article-title":"Detecting depression in Parkinson disease: a systematic review and meta-analysis","volume":"87","author":"Goodarzi","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib57","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/ijms24020915","article-title":"Understanding the role of oxidative stress, neuroinflammation and abnormal myelination in excessive aggression associated with depression: recent input from mechanistic studies","volume":"24","author":"Gorlova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106209_bib58","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00439-012-1145-7","article-title":"Genetics of dopamine receptors and drug addiction","volume":"131","author":"Gorwood","year":"2012","journal-title":"Hum. Genet"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/schbul\/sbad114","article-title":"Immune-inflammatory response and compensatory immune-regulatory reflex systems and white matter integrity in schizophrenia","volume":"50","author":"Gou","year":"2024","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2025.106209_bib60","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fpsyt.2020.00379","article-title":"Novel treatment strategies targeting myelin and oligodendrocyte dysfunction in schizophrenia","volume":"11","author":"Gouv\u00eaa-Junqueira","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"10111","key":"10.1016\/j.neubiorev.2025.106209_bib61","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib62","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuron.2024.10.019","article-title":"White matter aging and its impact on brain function","volume":"113","author":"Groh","year":"2025","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pharmrev.120.000133","article-title":"Therapeutics in the pipeline targeting alpha-synuclein for Parkinson\u2019s disease","volume":"74","author":"Grosso Jasutkar","year":"2022","journal-title":"Pharmacol. Rev."},{"issue":"24","key":"10.1016\/j.neubiorev.2025.106209_bib64","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1212\/WNL.0000000000001684","article-title":"Depression and subsequent risk of Parkinson's disease; a nationwide cohort study","volume":"84","author":"Gustafsson","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2025.106209_bib65","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41869","article-title":"Circulating transforming growth factor-\u03b21 facilitates remyelination in the adult central nervous system","volume":"8","author":"Hamaguchi","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.neubiorev.2025.106209_bib66","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.drugalcdep.2019.02.005","article-title":"Substance abuse and white matter: Findings, limitations, and future of diffusion tensor imaging research","volume":"197","author":"Hampton","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106209_bib67","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106209_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113935","article-title":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","volume":"177","author":"Hashimoto","year":"2020","journal-title":"Biochem. Pharm."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106209_bib69","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1038\/s41380-022-01587-7","article-title":"Ketamine: anesthetic, psychotomimetic, antidepressant, or anthelmintic?","volume":"27","author":"Hashimoto","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106209_bib70","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1038\/s41380-023-02287-6","article-title":"Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions","volume":"28","author":"Hashimoto","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106209_bib71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/bs.pbr.2023.01.003","article-title":"Neuroinflammation through the vagus nerve-dependent gut-microbiota-brain axis in treatment-resistant depression","volume":"278","author":"Hashimoto","year":"2023","journal-title":"Prog. Brain Res."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106209_bib72","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1038\/s41380-023-02161-5","article-title":"Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: the role of Epstein-Barr virus and the gut-brain axis","volume":"28","author":"Hashimoto","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106209_bib73","article-title":"Viewpoints Sigma-1 receptor agonist fluvoxamine for multiple sclerosis","volume":"37","author":"Hashimoto","year":"2024","journal-title":"Brain Behav. Immun. Health"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106209_bib74","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00406-013-0399-y","article-title":"Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders","volume":"263","author":"Hashimoto","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106209_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jatmed.2024.07.001","article-title":"Ketamine and its two enantiomers in anesthesiology and psychiatry: a historical review and future directions","volume":"3","author":"Hashimoto","year":"2024","journal-title":"J. Anes. Transl. Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib76","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jama.2022.23661","article-title":"Autism spectrum disorder: A review","volume":"329","author":"Hirota","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106209_bib77","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1176\/appi.ajp.2019.19030225","article-title":"The relationship between white matter microstructure and general cognitive ability in patients with schizophrenia and healthy participants in the ENIGMA consortium","volume":"177","author":"Holleran","year":"2020","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106209_bib78","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/s41380-023-02288-5","article-title":"Myelin-associated oligodendrocytic basic protein-dependent myelin repair confers the long-lasting antidepressant effect of ketamine","volume":"29","author":"Huang","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib79","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12264-024-01294-z","article-title":"Memory reconsolidation updating in substance addiction: applications, mechanisms, and future prospects for clinical therapeutics","volume":"41","author":"Huang","year":"2025","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib80","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12944-019-0965-z","article-title":"Role of cholesterol and sphingolipids in brain development and neurological diseases","volume":"18","author":"Hussain","year":"2019","journal-title":"Lipids Health Dis."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106209_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30193","article-title":"Associations among plasma markers for N-methyl-d-aspartate receptor hypofunction, redox dysregulation, and insufficient myelination in patients with schizophrenia","volume":"10","author":"Isomura","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.neubiorev.2025.106209_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106151","article-title":"The multiple sclerosis gut microbiome and disease activity: a systematic review","volume":"92","author":"Jette","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.neubiorev.2025.106209_bib83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neubiorev.2019.01.005","article-title":"From the microscope to the magnet: disconnection in schizophrenia and bipolar disorder","volume":"98","author":"Ji","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2025.106209_bib84","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s44220-023-00111-2","article-title":"White matter dysfunction in psychiatric disorders is associated with neurotransmitter and genetic profiles","volume":"1","author":"Ji","year":"2023","journal-title":"Nat. Ment. Health"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106209_bib85","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1503\/jpn.150341","article-title":"Microstructural brain abnormalities in medication-free patients with major depressive disorder: a systematic review and meta-analysis of diffusion tensor imaging","volume":"42","author":"Jiang","year":"2017","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106209_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102904","article-title":"Depression in multiple sclerosis: Is one approach for its management enough?","volume":"51","author":"Jones","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.neubiorev.2025.106209_bib87","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jad.2020.01.047","article-title":"White matter microstructural alterations in posttraumatic stress disorder: an ROI and whole-brain based meta-analysis","volume":"266","author":"Ju","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib88","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/jcm8020167","article-title":"White matter changes in patients with Alzheimer's disease and associated factors","volume":"8","author":"Kao","year":"2019","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106209_bib89","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106209_bib90","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/1352458520940983","article-title":"Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions","volume":"27","author":"Kassa","year":"2021","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106209_bib91","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archgenpsychiatry.2011.60","article-title":"Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder","volume":"68","author":"Kempton","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106209_bib92","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ana.26905","article-title":"Towards a global view of Parkinson's disease genetics","volume":"95","author":"Khani","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2025.106209_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108432","article-title":"Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis","volume":"246","author":"Kihara","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106209_bib94","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson's disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2025.106209_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1041961","article-title":"Overview of myelin, major myelin lipids, and myelin-associated proteins","volume":"10","author":"Kister","year":"2023","journal-title":"Front. Chem."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106209_bib96","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41582-022-00737-3","article-title":"Adaptive and maladaptive myelination in health and disease","volume":"18","author":"Knowles","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106209_bib97","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib98","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00001504-200503000-00004","article-title":"Evidence for white matter abnormalities in schizophrenia","volume":"18","author":"Kubicki","year":"2005","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FBP.0b013e3283242f05","article-title":"Genetics of dopamine receptors and drug addiction: a comprehensive review","volume":"20","author":"Le Foll","year":"2009","journal-title":"Behav. Pharm."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106209_bib100","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/biomedicines10050953","article-title":"Neuroinflammation in post-traumatic stress disorder","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106209_bib101","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1212\/WNL.0000000000009890","article-title":"Areas of white matter hyperintensities and motor symptoms of Parkinson disease","volume":"95","author":"Lee","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib102","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.parkreldis.2020.09.024","article-title":"Unmet needs in Parkinson disease: motor and non-motor","volume":"80","author":"LeWitt","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neubiorev.2025.106209_bib103","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ebiom.2016.01.012","article-title":"White matter abnormalities in post-traumatic stress disorder following a specific traumatic event","volume":"4","author":"Li","year":"2016","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106209_bib104","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11682-023-00791-5","article-title":"White matter alterations in mild cognitive impairment revealed by meta-analysis of diffusion tensor imaging using tract-based spatial statistics","volume":"17","author":"Li","year":"2023","journal-title":"Brain Imaging Behav."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106209_bib105","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/aur.2789","article-title":"Atypical structural connectivity of language networks in autism spectrum disorder: a meta-analysis of diffusion tensor imaging studies","volume":"15","author":"Li","year":"2022","journal-title":"Autism Res"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1503\/jpn.110180","article-title":"Is depression a disconnection syndrome? meta-analysis of diffusion tensor imaging studies in patients with MDD","volume":"38","author":"Liao","year":"2013","journal-title":"J. Psychiatry Neurosci."},{"issue":"15","key":"10.1016\/j.neubiorev.2025.106209_bib107","doi-asserted-by":"crossref","first-page":"e1562","DOI":"10.1212\/WNL.0000000000200006","article-title":"Relationship between white matter lesions and gray matter atrophy in multiple sclerosis: a systematic review","volume":"98","author":"Lie","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2025.106209_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104527","article-title":"Gut microbiota and its metabolites in depression: from pathogenesis to treatment","volume":"90","author":"Liu","year":"2023","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib109","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-019-0138-4","article-title":"Autism spectrum disorder","volume":"6","author":"Lord","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.neubiorev.2025.106209_bib110","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3389\/fphar.2017.00789","article-title":"Central administration of 5Z-7-oxozeaenol protects experimental autoimmune encephalomyelitis mice by inhibiting microglia activation","volume":"8","author":"Lu","year":"2017","journal-title":"Front. Pharm."},{"issue":"14","key":"10.1016\/j.neubiorev.2025.106209_bib111","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.neuron.2022.05.027","article-title":"The role of hippocampal KCNQ2 channel in antidepressant actions of ketamine","volume":"110","author":"Ma","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2025.106209_bib112","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2024.11.023","article-title":"The vagus nerve: an old but new player in brain-body communication","volume":"124","author":"Ma","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"10345","key":"10.1016\/j.neubiorev.2025.106209_bib113","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(22)00821-2","article-title":"Complex post-traumatic stress disorder","volume":"400","author":"Maercker","year":"2022","journal-title":"Lancet"},{"issue":"10161","key":"10.1016\/j.neubiorev.2025.106209_bib114","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2025.106209_bib115","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nicl.2015.11.019","article-title":"Translating state-of-the-art spinal cord MRI techniques to clinical use: a systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI","volume":"10","author":"Martin","year":"2015","journal-title":"Neuroimage Clin."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106209_bib116","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.tig.2021.04.012","article-title":"Multiple sclerosis: doubling down on MHC","volume":"37","author":"Martin","year":"2021","journal-title":"Trends Genet"},{"issue":"7942","key":"10.1016\/j.neubiorev.2025.106209_bib117","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-022-05534-y","article-title":"Microglia regulate central nervous system myelin growth and integrity","volume":"613","author":"McNamara","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2025.106209_bib118","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18246","article-title":"Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery","volume":"5","author":"Mei","year":"2016","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib119","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","article-title":"White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes","volume":"6","author":"Nasrabady","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neubiorev.2025.106209_bib120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-cellbio-100913-013101","article-title":"Myelination of the nervous system: mechanisms and functions","volume":"30","author":"Nave","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib121","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s12325-020-01570-0","article-title":"Annual cost burden by level of relapse severity in patients with multiple sclerosis","volume":"38","author":"Nicholas","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.neubiorev.2025.106209_bib122","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6436453","article-title":"Regulation of central nervous system myelination in higher brain functions","volume":"2018","author":"Nickel","year":"2018","journal-title":"Neural Plast."},{"issue":"14","key":"10.1016\/j.neubiorev.2025.106209_bib123","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jama.2023.18588","article-title":"Diagnosis and treatment of bipolar disorder: A review","volume":"330","author":"Nierenberg","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106209_bib124","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrn3939","article-title":"The dopamine theory of addiction: 40 years of highs and lows","volume":"16","author":"Nutt","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/tomography11010008","article-title":"Comparative sensitivity of MRI indices for myelin assessment in spinal cord regions","volume":"11","author":"Oppong","year":"2025","journal-title":"Tomography"},{"key":"10.1016\/j.neubiorev.2025.106209_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1030486","article-title":"Heterogeneity and regulation of oligodendrocyte morphology","volume":"10","author":"Osanai","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib127","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41398-020-01128-2","article-title":"Gray and white matter morphology in substance use disorders: a neuroimaging systematic review and meta-analysis","volume":"11","author":"Pando-Naude","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106209_bib128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","article-title":"The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl. Neurodegener."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106209_bib129","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae140","article-title":"Pathophysiology in cortico-amygdala circuits and excessive aversion processing: the role of oligodendrocytes and myelination","volume":"6","author":"Poggi","year":"2024","journal-title":"Brain Commun."},{"issue":"32","key":"10.1016\/j.neubiorev.2025.106209_bib130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2407974121","article-title":"Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis","volume":"121","author":"Poon","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106209_bib131","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s13760-020-01322-5","article-title":"White matter changes from mild cognitive impairment to Alzheimer's disease: a meta-analysis","volume":"121","author":"Qin","year":"2021","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.neubiorev.2025.106209_bib132","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1146\/annurev-psych-010814-015340","article-title":"Diffusion tensor imaging for understanding brain development in early life","volume":"66","author":"Qiu","year":"2015","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neubiorev.2025.106209_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1476701","article-title":"Total burden of cerebral small vessel disease predict subjective cognitive decline in patients with Parkinson's disease","volume":"16","author":"Qiu","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106209_bib134","doi-asserted-by":"crossref","first-page":"e874","DOI":"10.1111\/hsc.13687","article-title":"Multiple sclerosis caregiving: A systematic scoping review to map current state of knowledge","volume":"30","author":"Rajachandrakumar","year":"2022","journal-title":"Health Soc. Care. Community"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106209_bib136","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41582-023-00789-z","article-title":"A global view of the genetic basis of Alzheimer disease","volume":"19","author":"Reitz","year":"2023","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib137","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12939-020-01287-0","article-title":"Unmet mental health needs in the general population: perspectives of Belgian health and social care professionals","volume":"19","author":"Rens","year":"2020","journal-title":"Int J. Equity Health"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib138","doi-asserted-by":"crossref","first-page":"i48","DOI":"10.1136\/jnnp.2004.060426","article-title":"Depression in neurological disorders: Parkinson\u2019s disease, multiple sclerosis, and stroke","volume":"76","author":"Rickards","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib139","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.schres.2014.09.026","article-title":"White matter microstructure in schizophrenia: associations to neurocognition and clinical symptomatology","volume":"161","author":"Roalf","year":"2015","journal-title":"Schizophr. Res."},{"issue":"20","key":"10.1016\/j.neubiorev.2025.106209_bib140","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.3390\/ijms21207537","article-title":"Sphingosine-1-phosphate receptor modulators and oligodendroglial cells: beyond immunomodulation","volume":"21","author":"Roggeri","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2025.106209_bib141","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.conb.2017.09.013","article-title":"Myelin dynamics: protecting and shaping neuronal functions","volume":"47","author":"Saab","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neubiorev.2025.106209_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177080","article-title":"The next frontier in multiple sclerosis therapies: current advances and evolving targets","volume":"985","author":"Sastri","year":"2024","journal-title":"Eur. J. Pharm."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106209_bib143","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson\u2019s disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106209_bib144","first-page":"546","article-title":"A review of PTSD and current treatment strategies","volume":"118","author":"Schrader","year":"2021","journal-title":"Mo. Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/schbul\/sbac169","article-title":"Sex- and age-specific deviations in cerebellar structure and their link with symptom dimensions and clinical outcome in individuals at clinical high risk for psychosis","volume":"49","author":"Sefik","year":"2023","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2025.106209_bib146","unstructured":"Sharma, R., Sekhon, S., Lui, F., Cascella, M., 2024. White matter lesions. StatPearls Publishing."},{"key":"10.1016\/j.neubiorev.2025.106209_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102290","article-title":"Remyelinating strategies: what can be learned from normal brain development","volume":"67","author":"Shelestak","year":"2022","journal-title":"Curr. Opin. Pharm."},{"key":"10.1016\/j.neubiorev.2025.106209_bib148","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.nicl.2018.05.013","article-title":"Structural white matter changes in adults and children with posttraumatic stress disorder: a systematic review and meta-analysis","volume":"19","author":"Siehl","year":"2018","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.neubiorev.2025.106209_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1343463","article-title":"White matter hyperintensities in bipolar disorder: systematic review and meta-analysis","volume":"15","author":"Silva","year":"2024","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106209_bib150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/B978-0-323-90242-7.00016-X","article-title":"Modification of T- and B-cell-associated immuno-pathologic mechanisms in multiple sclerosis by disease modifying therapies: Achievements and opportunities","volume":"202","author":"Smolders","year":"2024","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib151","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.neubiorev.2025.106209_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100180","article-title":"HPA axis function and diurnal cortisol in post-traumatic stress disorder: a systematic review","volume":"11","author":"Speer","year":"2019","journal-title":"Neurobiol. Stress"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib153","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41398-022-01809-0","article-title":"A coordinate-based meta-analysis of white matter alterations in patients with alcohol use disorder","volume":"12","author":"Spindler","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106209_bib154","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00031.2018","article-title":"Myelin in the central nervous system: structure, function, and pathology","volume":"99","author":"Stadelmann","year":"2019","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00011-023-01829-6","article-title":"Sphingosine 1-phosphate (S1P) receptor modulators as an induction and maintenance therapy for ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials","volume":"73","author":"Suilik","year":"2024","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.neubiorev.2025.106209_bib156","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jad.2024.01.147","article-title":"Based on white matter microstructure to early identify bipolar disorder from patients with depressive episode","volume":"350","author":"Sun","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106209_bib157","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S1474-4422(18)30245-X","article-title":"Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study","volume":"17","author":"Trapp","year":"2018","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106209_bib158","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/aur.1243","article-title":"Diffusion tensor imaging in autism spectrum disorder: a review","volume":"5","author":"Travers","year":"2012","journal-title":"Autism Res"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib159","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41531-023-00568-z","article-title":"Linking environmental risk factors with epigenetic mechanisms in Parkinson's disease","volume":"9","author":"Tsalenchuk","year":"2023","journal-title":"NPJ Park. Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib160","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5498\/wjp.v12.i2.264","article-title":"Insights into myelin dysfunction in schizophrenia and bipolar disorder","volume":"12","author":"Vald\u00e9s-Tovar","year":"2022","journal-title":"World J. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106209_bib161","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/s41380-019-0477-2","article-title":"White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group","volume":"25","author":"van Velzen","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106209_bib162","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nicl.2016.06.013","article-title":"Cerebral white matter structure is associated with DSM-5 schizophrenia symptom dimensions","volume":"12","author":"Viher","year":"2016","journal-title":"Neuroimage Clin."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib163","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12888-016-0932-4","article-title":"White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids","volume":"16","author":"Vijayakumar","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106209_bib164","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrn.2017.130","article-title":"The dopamine motive system: implications for drug and food addiction","volume":"18","author":"Volkow","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106209_bib165","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neubiorev.2025.106209_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105782","article-title":"Cognitive and brain morphological deviations in middle-to-old aged autistic adults: a systematic review and meta-analysis","volume":"163","author":"Wang","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2025.106209_bib167","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jpsychires.2014.05.005","article-title":"White matter lesions and depression: a systematic review and meta-analysis","volume":"56","author":"Wang","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2025.106209_bib168","article-title":"Fingolimod ameliorates amyloid deposition and neurodegeneration in APP\/PS1 mouse model of Alzheimer's disease","volume":"2025 Mar 29","author":"Wang","year":"2025","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2025.106209_bib169","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pnpbp.2018.05.025","article-title":"Association between depression and the subsequent risk of Parkinson's disease: a meta-analysis","volume":"86","author":"Wang","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106209_bib170","article-title":"Myelin Repair as a Novel Mechanism for Ketamine's Sustained Antidepressant Effects","author":"Wang","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neubiorev.2025.106209_bib171","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.brainresbull.2021.10.013","article-title":"R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in mice","volume":"177","author":"Wang","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2025.106209_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105635","article-title":"R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: a role of gut-microbiota-brain axis","volume":"165","author":"Wang","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2025.106209_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104762","article-title":"R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression","volume":"139","author":"Wang","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2025.106209_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105951","article-title":"Key role of the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain","volume":"176","author":"Wang","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2025.106209_bib175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.euroneuro.2021.04.010","article-title":"Intranasal administration of transforming growth factor-\u03b21 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: a role of TrkB signaling","volume":"50","author":"Wei","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106209_bib176","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainresbull.2022.02.008","article-title":"Brain-spleen axis in health and diseases: a review and future perspective","volume":"182","author":"Wei","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib177","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106209_bib178","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301557RR","article-title":"The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelination and induces oligodendrocyte differentiation","volume":"38","author":"Willems","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.neubiorev.2025.106209_bib179","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fneur.2018.00092","article-title":"Understanding the physiopathology behind axial and radial diffusivity changes-What do we know?","volume":"9","author":"Winklewski","year":"2018","journal-title":"Front. Neurol."},{"issue":"21","key":"10.1016\/j.neubiorev.2025.106209_bib180","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.neuron.2024.08.003","article-title":"Gut-induced alpha-synuclein and tau propagation initiate Parkinson's and Alzheimer's disease co-pathology and behavior impairments","volume":"112","author":"Xiang","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2025.106209_bib181","article-title":"Transforming growth factor \u03b21 protects against ischemic demyelination via regulating microglial lipid metabolism pathway","author":"Xie","year":"2025","journal-title":"Stroke 2025 Mar. 31"},{"key":"10.1016\/j.neubiorev.2025.106209_bib182","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jad.2024.08.222","article-title":"Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-\u03b21","volume":"367","author":"Xu","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106209_bib183","doi-asserted-by":"crossref","first-page":"170","DOI":"10.31083\/j.jin2309170","article-title":"Shared and distinct white matter alterations in major depression and bipolar disorder: a systematic review and meta-analysis","volume":"23","author":"Xu","year":"2024","journal-title":"J. Integr. Neurosci."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106209_bib184","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib185","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41531-023-00592-z","article-title":"White matter changes in Parkinson's disease","volume":"9","author":"Yang","year":"2023","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.neubiorev.2025.106209_bib186","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","article-title":"Current and projected future economic burden of Parkinson's disease in the U.S","volume":"6","author":"Yang","year":"2020","journal-title":"NPJ Park. Dis."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106209_bib187","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41380-021-01377-7","article-title":"Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine","volume":"27","author":"Yao","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106209_bib188","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neubiorev.2017.10.026","article-title":"White matter microstructural abnormalities in amnestic mild cognitive impairment: A meta-analysis of whole-brain and ROI-based studies","volume":"83","author":"Yu","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2025.106209_bib189","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41398-020-0733-x","article-title":"Essential role of microglial transforming growth factor-\u03b21 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-\u03b21","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib191","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","article-title":"Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib192","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer's disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib193","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/schbul\/sbab093","article-title":"A comparative multimodal meta-analysis of anisotropy and volume abnormalities in white matter in people suffering from bipolar disorder or schizophrenia","volume":"48","author":"Zhao","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2025.106209_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177096","article-title":"Transforming growth factor-\u03b21 mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice","volume":"985","author":"Zhao","year":"2024","journal-title":"Eur. J. Pharm."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106209_bib195","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.3390\/ijms24076373","article-title":"Mechanisms of demyelination and remyelination strategies for multiple sclerosis","volume":"24","author":"Zhao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib196","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41380-020-00930-0","article-title":"Oligodendrocyte lineage cells and depression","volume":"26","author":"Zhou","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106209_bib197","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1038\/s41380-019-0475-4","article-title":"Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice","volume":"25","author":"Zhu","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106209_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106375","article-title":"Clemastine-induced enhancement of hippocampal myelination alleviates memory impairment in mice with chronic pain","volume":"190","author":"Zhu","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2025.106209_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111228","article-title":"Arketamine alleviates cognitive impairments and demyelination in mice with postoperative cognitive dysfunction via TGF-\u03b21 activation","author":"Zhu","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry136"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106209_bib200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","article-title":"Blood-brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies","volume":"23","author":"Zierfuss","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2025.106209_bib201","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pscychresns.2018.09.004","article-title":"White matter microstructural correlates of relapse in alcohol dependence","volume":"281","author":"Zou","year":"2018","journal-title":"Psychiatry Res. Neuroimaging"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976342500209X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976342500209X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T04:15:16Z","timestamp":1778386516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014976342500209X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":201,"alternative-id":["S014976342500209X"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106209","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Demyelination in psychiatric and neurological disorders: Mechanisms, clinical impact, and novel therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106209"}}